Selkirk Pharma Expands with APS Qualified Facility and Advanced Fill/Finish Capabilities

• Selkirk Pharma announces the establishment of a new APS Qualified Facility.

• The new facility is equipped with advanced fill/finish capacity and is located in Spokane,WA.

Selkirk Pharma has announced the opening of a new APS Qualified Facility, marking a significant milestone in the company’s growth. The facility, located in Spokane, WA, boasts advanced fill/finish capacity, further strengthening Selkirk Pharma’s position as a CDMO (Contract Development and Manufacturing Organisation).

“The completion of our facility’s aseptic process simulation qualification is a milestone achievement for the Selkirk team,” said John Bertagnolli, Vice President of Operations at Selkirk Pharma. “It was made possible by the hard work of our exceptional employees and through the support of many others. We are excited to offer this qualified, reliable, fill/finish capacity to our customers, and most importantly, to their patients.”

The Spokane-based facility is APS Qualified, a designation that underscores Selkirk Pharma’s adherence to stringent quality standards. This qualification is a key differentiator in the competitive landscape of contract manufacturing, and it further enhances Selkirk Pharma’s reputation for delivering high-quality services.